November 17, 2023

Medical Affairs Communications Team of the Year: Oxford PharmaGenesis colleagues win prestigious 2023 PharmaTimes award

Congratulations to Oxford PharmaGenesis colleagues who were named Medical Affairs Communications Team of the Year at the PharmaTimes gala dinner and awards ceremony on Thursday 16 November!

  • All
  • News
  • Articles
  • Events
Open access

Benchmarking open access in publications with authors affiliated to pharma companies and universities

Many scientific and medical publications lie behind a paywall. New medical research is increasingly being published as ‘open access’, which makes articles freely available to anyone. This provides major benefits because it gives researchers and members of the public equal access to medical knowledge. It also improves research transparency, which helps to foster public trust.

Continue reading

ISMPP Academy report: Oxford PharmaGenesis teaches how to elevate publications through enhanced impact and demystifies RWE and HEOR

More than 150 medical publications professionals gathered in Philadelphia on 28–29 September 2023 for the inaugural ISMPP Academy. Oxford PharmaGenesis was a key event sponsor and we were delighted to give two valuable presentations to help attendees to explore new frontiers in publications. In line with the ISMPP Academy theme ‘PREP! Practical Resources to Elevate…

Continue reading

Celebrating five colleagues who have dedicated more than 20 years to Oxford PharmaGenesis

We are thrilled to celebrate five colleagues who have dedicated more than 20 years to Oxford PharmaGenesis! They have helped to deliver everything from traditional medical communications to innovative patient engagement materials, not only serving our clients but also advancing our company mission along the way.

Continue reading
Clinical study publication

Factors influencing the time it takes for the results from pharmaceutical industry-affiliated clinical studies to be published

The publication of clinical study results is key to communicating how well medicines can treat diseases. It is vital that these results are made available as quickly as possible, so it’s important to know what influences the ‘time to publication’ (the time from the end of the study to publication of the results in a…

Continue reading

ISMPP Academy | Elevate and enrich publications plans with Oxford PharmaGenesis

Effective innovation happens when we ask big questions. It’s part of what makes Oxford PharmaGenesis an award-winning, independent, global HealthScience communications consultancy. We innovate for clients through our transformative services. We offer expertise in publications, strategic medical communications, informatics and data science, patient engagement, value demonstration, Open Pharma, social media, and more.

Continue reading

Use of ORCID digital identity tags in research funded by pharma companies

ORCID iDs are digital identity tags for authors of research papers. Authors who sign up to ORCID are given a unique number, which is linked to an online profile where they can add information about where they work and their education, awards and published works. Authors can add their ORCID iD to any research papers…

Continue reading